Abstract

At present, cardiovascular and cerebrovascular diseases seriously threaten human life and health, and the development of nanodrug delivery systems has brought about a turnaround for traditional drug treatments, with nanoparticles being precisely targeted to improve bioavailability. In addition, surface modification of nanoparticles can prolong blood circulation time and enhance targeting ability. The application of cell membrane-coated nanoparticles further improves their biocompatibility and active targeting ability, providing new hope for the treatment of cardiovascular and cerebrovascular diseases. In recent years, various types of cell membrane biomimetic nanoparticles have gradually attracted increasing attention due to their unique advantages. However, the single-cell membrane has several limitations because a single functional property cannot fully meet the requirements of cardiovascular and cerebrovascular disease treatment. Hybrid cell membranes integrate the advantages of multiple biological membranes and have become an emerging research hotspot. This review summarizes the application of single-cell membrane biomimetic nanoparticles in the treatment of cardiovascular and cerebrovascular diseases and discusses the advantages, challenges and future development of biomimetic nanoparticles. We propose that the fusion of multiple membranes may be a reasonable trend in the future to provide some ideas and directions for the treatment of cardiovascular and cerebrovascular diseases.